Sionna Therapeutics, Inc. (SION)
NASDAQ: SION · Real-Time Price · USD
36.53
-1.49 (-3.92%)
At close: Feb 11, 2026, 4:00 PM EST
37.45
+0.92 (2.52%)
After-hours: Feb 11, 2026, 7:03 PM EST
Sionna Therapeutics Employees
Sionna Therapeutics had 48 employees as of March 31, 2025. The number of employees increased by 7 or 17.07% since the number was last reported on December 31, 2024.
Employees
48
Change
7
Growth
17.07%
Revenue / Employee
n/a
Profits / Employee
-$1,472,417
Market Cap
1.63B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 48 | 7 | 17.07% |
| Dec 31, 2024 | 41 | 13 | 46.43% |
| Dec 31, 2023 | 28 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Immunocore Holdings | 493 |
| Nurix Therapeutics | 317 |
| Zymeworks | 263 |
| Celldex Therapeutics | 186 |
| Tango Therapeutics | 155 |
| Precigen | 143 |
| Innoviva | 127 |
| Enliven Therapeutics | 65 |
SION News
- 7 days ago - Sionna Therapeutics to Present at the Guggenheim Securities Emerging Outlook: Biotech Summit 2026 - GlobeNewsWire
- 4 weeks ago - Sionna Therapeutics, Inc. (SION) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 5 weeks ago - Sionna Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - Sionna Therapeutics, Inc. (SION) Presents at Citi Annual Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 2 months ago - Sionna Therapeutics to Participate in Upcoming December Investor Conferences - GlobeNewsWire
- 3 months ago - Sionna Therapeutics Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 3 months ago - Sionna Therapeutics to Participate in Upcoming November Investor Conferences - GlobeNewsWire
- 3 months ago - Sionna Therapeutics Announces Presentation of SION-719 and SION-451 Phase 1 Data and Poster of New Preclinical Data on the Impact of NBD1 Stabilizers on F508del-CFTR Half-Life at the 2025 North American Cystic Fibrosis Conference - GlobeNewsWire